These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8331235)

  • 1. CT and MR accuracy in the detection of tumor recurrence in patients treated for ovarian cancer.
    Prayer L; Kainz C; Kramer J; Stiglbauer R; Schurawitzki H; Baldt M; Schima W; Poelzleitner D; Reinthaller A; Koelbl H
    J Comput Assist Tomogr; 1993; 17(4):626-32. PubMed ID: 8331235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.
    Torizuka T; Nobezawa S; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Takekuma M; Maeda M; Ouchi Y
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):797-803. PubMed ID: 12029554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of positron emission tomography-CT imaging combined with continual detection of CA125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma].
    Sheng XG; Zhang XL; Fu Z; Li HQ; Li QS; Ma ZF; Li DP; Chen ZY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):460-3. PubMed ID: 17961335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients.
    Nanni C; Rubello D; Farsad M; De Iaco P; Sansovini M; Erba P; Rampin L; Mariani G; Fanti S
    Eur J Surg Oncol; 2005 Sep; 31(7):792-7. PubMed ID: 15893908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abdominal recurrence of ovarian cancer: value of abdominal MR in patients with positive CA125 and negative CT.
    Balestreri L; Bison L; Sorio R; Morra A; Campagnutta E; Morassut S
    Radiol Med; 2002; 104(5-6):426-36. PubMed ID: 12589264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy of CT in detection of persistent or recurrent ovarian carcinoma: correlation with second-look laparotomy.
    Megibow AJ; Bosniak MA; Ho AG; Beller U; Hulnick DH; Beckman EM
    Radiology; 1988 Feb; 166(2):341-5. PubMed ID: 3336709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT.
    Bristow RE; del Carmen MG; Pannu HK; Cohade C; Zahurak ML; Fishman EK; Wahl RL; Montz FJ
    Gynecol Oncol; 2003 Sep; 90(3):519-28. PubMed ID: 13678719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic value of magnetic resonance imaging for the detection of tumor recurrence in patients with carcinoma of the ovaries.
    Kainz C; Prayer L; Gitsch G; Stiglbauer R; Kramer J; Reinthaller A; Kölbl H
    J Am Coll Surg; 1994 Mar; 178(3):239-44. PubMed ID: 8149015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
    Kim CK; Park BK; Choi JY; Kim BG; Han H
    J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer.
    Topuz E; Aydiner A; Saip P; Eralp Y; Taş F; Salihoğlu Y; Tenekeci N
    Eur J Gynaecol Oncol; 2000; 21(6):599-602. PubMed ID: 11214619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer.
    Sanli Y; Turkmen C; Bakir B; Iyibozkurt C; Ozel S; Has D; Yilmaz E; Topuz S; Yavuz E; Unal SN; Mudun A
    Nucl Med Commun; 2012 May; 33(5):509-15. PubMed ID: 22357440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of preoperative diagnosis before second-look laparotomy in ovarian cancer].
    Meden H; Rath W; Ohlmeyer D
    Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):101-5. PubMed ID: 2180783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis.
    Gu P; Pan LL; Wu SQ; Sun L; Huang G
    Eur J Radiol; 2009 Jul; 71(1):164-74. PubMed ID: 18378417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study.
    Guo N; Peng Z
    J Ovarian Res; 2017 Mar; 10(1):14. PubMed ID: 28284216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of [18F]FDG-PET/CT and CA125, serum levels and kinetic parameters, in early detection of ovarian cancer recurrence: Influence of histological subtypes and tumor stages.
    Palomar Muñoz A; Cordero García JM; Talavera Rubio MDP; García Vicente AM; Pena Pardo FJ; Jiménez Londoño GA; Soriano Castrejón Á; Aranda Aguilar E
    Medicine (Baltimore); 2018 Apr; 97(17):e0098. PubMed ID: 29702969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer.
    Takekuma M; Maeda M; Ozawa T; Yasumi K; Torizuka T
    Int J Clin Oncol; 2005 Jun; 10(3):177-81. PubMed ID: 15990965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation on non invasive diagnostic tests for the second look in epithelial ovarian cancer].
    García Enguídanos A; Crespo Azanza E; Díaz Recaséns J; Lobo Samper F; Jorge Herrero JA; Sáinz de la Cuesta Abbad R
    Rev Clin Esp; 1998 Aug; 198(8):502-5. PubMed ID: 9774878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of second-look laparotomy for ovarian cancer: second-look vs. serum CA125.
    Liu L; Hong W; Hou Y; Yao Z; Wu A; Wang X
    Chin Med Sci J; 1991 Jun; 6(2):96-9. PubMed ID: 1804384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An early detection of the recurrence of serous cystadenocarcinoma of the ovary with the tumor marker CA125 levels].
    Usui N; Suzuki M; Takada M
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jun; 44(6):703-9. PubMed ID: 1506732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Computerized tomography and magnetic resonance in the diagnosis of recurrent rectal neoplasms: comparison of reliability and errors of both methods].
    Golfieri R; Totaro C; Giampalma E; Lalli A; Sbrozzi F; Soro A; Nogara G; Gavelli G
    Radiol Med; 1996 May; 91(5):601-9. PubMed ID: 8693127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.